Circhem Ab Stock Beneish M Score
CIRCHE Stock | SEK 2.84 0.10 3.40% |
CirChem |
At this time, CirChem AB's M Score is inapplicable. The earnings manipulation may begin if CirChem AB's top management creates an artificial sense of financial success, forcing the stock price to be traded at a high price-earnings multiple than it should be. In general, excessive earnings management by CirChem AB executives may lead to removing some of the operating profits from subsequent periods to inflate earnings in the following periods. This way, the manipulation of CirChem AB's earnings can lead to misrepresentations of actual financial condition, taking the otherwise loyal stakeholders on to the path of questionable ethical practices and plain fraud.
-4.84
Beneish M Score - Inapplicable
Did you try this?
Run Portfolio Optimization Now
Portfolio OptimizationCompute new portfolio that will generate highest expected return given your specified tolerance for risk |
All Next | Launch Module |
About CirChem AB Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CirChem AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CirChem AB using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CirChem AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in CirChem Stock
CirChem AB financial ratios help investors to determine whether CirChem Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CirChem with respect to the benefits of owning CirChem AB security.